Replies to post #140063 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

"In June 2014, Friedland and his wife hosted a dinner at their home in Denver, Colorado, where a presentation was made about the developing field of medical marijuana research by a doctor who later became OWC’s chief science officer. The guests at this dinner included approximately 25 potential investors, among them doctors and business people, two of whom made private investments in OWC (then called Dynamic Applications) via subscription agreements shortly after the dinner at Friedland’s house."

And in November 2014 Bignitz Incorporated OWCP. You have to love how these OTCM scams fall apart upon closer inspection.

For the Fiscal Year ending on December 31, 2014: The Company's research initiatives are directed by Dr. Yehuda Baruch

Mordechai Bignitz Chief Executive Officer and Chairman

IG

[I-Glow]

Where is the S-1 that OWCP has to file and it be declared Effective.

You do understand this nonsense has happened before. I am feeling very generous - let me provide some help and guidance.

What Happened to the Kodiak Equity Purchase Agreement from January 2016?

OWCP Filed a S-1 but withdrew it and it was never declared effective. That seems like it was used for pumping purposes only - just as the most recent Equity Purchase Agreement.

"PETACH-TIKVA, Israel, January 11, 2016 /PRNewswire/ --

OWC Pharmaceutical Research Corp. (OTC: OWCP), an Israel-based pharmaceutical research company dedicated to the development of cannabinoid treatments, products and delivery technologies, today announced that it has entered into a $750,000 equity purchase agreement ("Agreement") with Kodiak Capital Group, LLC ("Kodiak")."

https://www.otcmarkets.com/stock/OWCP/news/OWC-Pharmaceutical-Research-Announces-750K-Equity-Purchase-Agreement-With-Kodiak-Capital-Group?id=122888

This is a the same type of deal it will never be consummated.

IG